Wednesday, July 8, 2026

pharma · Advanced Solid Tumor · Acute Myeloid Leukemia or Myelodysplastic Syndromes · APRE

Aprea Therapeutics

Aprea Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.

3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US HQ
15 Employees
Public company Type
APRE · NYSE Ticker
Company details
Status
Public
HQ
3805 Old Easton Rd, Doylestown, Pennsylvania 18902, US
Employees
15
Programs
15
Drugs
5
Patents
6
Intelligence · Clinical Trials

Aprea Therapeutics clinical trials

Registry index of 15 ClinicalTrials.gov studies linked to Aprea Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Aprea Therapeutics trial registry — 15 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Aprea Therapeutics.

  1. APR-246 — Phase 2

    Clinical update
  2. APR-246 — Phase 1

    Clinical update
  3. APR-246 + azacitidine — Phase 3

    Clinical update
  4. APR-246 — Phase 2

    Clinical update
  5. APR-246 — Phase 2

    Clinical update
  6. APR-246 — Phase 2

    Clinical update
  7. APR-246 — Phase 2

    Clinical update
  8. APR-246 — Phase 2

    Clinical update

Trial registry

15 studies